Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03397654
Title Study of Pembrolizumab Following TACE in Primary Liver Carcinoma (PETAL)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Imperial College London
Age Groups: adult | senior
Covered Countries

No variant requirements are available.